Literature DB >> 7530758

Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody.

J Ogasawara1, T Suda, S Nagata.   

Abstract

Fas is a cell surface protein that mediates apoptosis. A mouse mutant, lpr (lymphoproliferation), has a mutation in the Fas gene. In this report, we studied the expression and function of Fas in various subpopulations of mouse thymocytes. Abundant expression of Fas was detected on CD4+CD8+ double positive as well as CD4+ or CD8+ single positive thymocytes in wild-type mice. Little or low levels of Fas were expressed in CD4-CD8- double negative thymocytes except for the CD4-CD8-CD3+ phenotype, which expresses Fas as abundantly as double positive or single positive subsets. On the other hand, no Fas expression was detected in any population of thymocytes from lpr mice. When the wild-type thymocytes were treated with the agonistic anti-Fas antibody, double positive cells from the wild-type mice were selectively killed by apoptosis, whereas, the single positive cells were resistant to its cytolytic activity despite their abundant expression of Fas. Unlike the apoptosis of thymocytes induced by glucocorticoid or T cell activator, the Fas-induced apoptosis of thymocytes was enhanced by metabolic inhibitors such as cycloheximide. Furthermore, intraperitoneal administration of the anti-Fas antibody into mice caused rapid apoptosis of thymocytes in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7530758      PMCID: PMC2191897          DOI: 10.1084/jem.181.2.485

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  41 in total

1.  The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen.

Authors:  R Watanabe-Fukunaga; C I Brannan; N Itoh; S Yonehara; N G Copeland; N A Jenkins; S Nagata
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

Review 2.  Fas and Fas ligand: a death factor and its receptor.

Authors:  S Nagata
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

3.  Differential expression of APO-1 on human thymocytes: implications for negative selection?

Authors:  K M Debatin; D Süss; P H Krammer
Journal:  Eur J Immunol       Date:  1994-03       Impact factor: 5.532

Review 4.  Negative selection of lymphocytes.

Authors:  G J Nossal
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 5.  Positive selection of lymphocytes.

Authors:  H von Boehmer
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

6.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death.

Authors:  J J Cohen; R C Duke
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

7.  The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.

Authors:  J Drappa; N Brot; K B Elkon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

9.  Fas transduces activation signals in normal human T lymphocytes.

Authors:  M R Alderson; R J Armitage; E Maraskovsky; T W Tough; E Roux; K Schooley; F Ramsdell; D H Lynch
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  Purification and characterization of the Fas-ligand that induces apoptosis.

Authors:  T Suda; S Nagata
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  45 in total

1.  A Fas pathway to pulmonary fibrosis.

Authors:  H A Chapman
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

2.  Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication.

Authors:  C M Simbulan-Rosenthal; D S Rosenthal; S Iyer; H Boulares; M E Smulson
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

3.  Moloney murine leukemia virus-induced tumors show altered levels of proapoptotic and antiapoptotic proteins.

Authors:  C Bonzon; H Fan
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis.

Authors:  Yuhang Zhang; Stephen Rosenberg; Hanming Wang; Hongxia Z Imtiyaz; Ying-Ju Hou; Jianke Zhang
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

5.  Kinetics of Fas-induced apoptosis in thymic organ culture.

Authors:  T Zhou; M Fleck; U Müeller-Ladner; P Yang; Z Wang; S Gay; S Matsumoto; J D Mountz
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

6.  Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress.

Authors:  M Oka; K Hirazawa; K Yamamoto; N Iizuka; S Hazama; T Suzuki; N Kobayashi
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

7.  A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis.

Authors:  G Gil-Gómez; A Berns; H J Brady
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

8.  Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway.

Authors:  D Ashany; X Song; E Lacy; J Nikolic-Zugic; S M Friedman; K B Elkon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

9.  A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis.

Authors:  J Zhang; A Winoto
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

10.  Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway.

Authors:  F Weih; R P Ryseck; L Chen; R Bravo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.